Graf Akcie PACB (Pacific Biosciences of California Inc). Diskuze k akciím PACB. Aktuální informace PACB.

Základní informace o společnosti Pacific Biosciences of California Inc (Akcie PACB)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 5.12B
Hodnota podniku (EV) N/A
Tržby 105.825M
EBITDA N/A
Zisk -77.21
Růst v tržbách Q/Q 79.25 %
Růst v tržbách Y/Y 28.24 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -115.41
EV/Sales 53.39
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 48.36
P/FCF N/A
Price/Book 15.25
Účetní hodnota na akcii 1.61
Hotovost na akcii 1.53
FCF vůči ceně -1.44 %
Počet zaměstnanců 412
Tržba na zaměstnance 256.857k
Profit margin 37.27 %
Operating margin -112.86 %
Gross margin 41.28 %
EBIT margin -67.88 %
EBITDA margin -113.69 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 40.00 %
EPS - Očekávaný růst příští rok 50.00 %
Return on assets -9.61 %
Return on equity -30.77 %
ROIC 10.56 %
ROCE -5.98 %
Dluhy/Equity 0.23
Čistý dluh/EBITDA 3.61
Current ratio 26.17
Quick Ratio 25.78
Volatilita 5.78
Beta 2.27
RSI 42.00
Cílová cena analytiků 14
Známka akcie (dle analytiků) 2.20
Insider ownership 6.73 %
Institutional ownership 91.04 %
Počet akcií 199.198M
Procento shortovaných akcií 8.44 %
Short ratio 8.16 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2010
Země United States

Finanční výsledky akcie PACB

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$90.891$78.626$93.468$90.714$92.782$60.594
Cost Of Goods Sold$56.315$53.53$58.809$46.554$39.332$37.192
Gross Profit$34.576$25.096$34.659$44.16$53.45$23.402
Research And Development Expenses$59.63$62.594$65.324$67.617$60.44$48.23
SG&A Expenses$75.491$63.489$59.119$47.787$45.187$38.026
Other Operating Income Or Expenses----$23.043-
Operating Expenses$191.436$179.613$183.252$161.958$121.916$123.448
Operating Income$-100.545$-100.987$-89.784$-71.244$-29.134$-62.854
Total Non-Operating Income/Expense$16.411$-1.575$-2.405$-3.131$-2.562$-3.306
Pre-Tax Income$-84.134$-102.562$-92.189$-74.375$-31.696$-66.16
Income Taxes------
Income After Taxes$-84.134$-102.562$-92.189$-74.375$-31.696$-66.16
Other Income------
Income From Continuous Operations$-84.134$-102.562$-92.189$-74.375$-31.696$-66.16
Income From Discontinued Operations------
Net Income$-84.134$-102.562$-92.189$-74.375$-31.696$-66.16
EBITDA$-89.385$-92.748$-80.139$-66.211$-24.5$-57.84
EBIT$-100.545$-100.987$-89.784$-71.244$-29.134$-62.854
Basic Shares Outstanding153135106897670
Shares Outstanding153135106897670
Basic EPS$-0.55$-0.76$-0.87$-0.83$-0.42$-0.94
EPS - Earnings Per Share$-0.55$-0.76$-0.87$-0.83$-0.42$-0.94
# 2020 2019 2018 2017 2016 2015
Current Ratio1.64894.89733.54883.22772.89543.7397
Long-term Debt / Capital-0.11390.13670.15980.16890.2029
Debt/Equity Ratio0.2890.12850.15840.19020.20330.2546
Gross Margin38.041231.918237.081148.680557.608238.621
Operating Margin-110.6215-128.4397-96.0585-78.5369-31.4005-103.7297
EBIT Margin-110.6215-128.4397-96.0585-78.5369-31.4005-103.7297
EBITDA Margin-98.3431-117.961-85.7395-72.9887-26.406-95.455
Pre-Tax Profit Margin-92.5658-130.4429-98.6316-81.9884-34.1618-109.1857
Net Profit Margin-92.5658-130.4429-98.6316-81.9885-34.1618-109.1857
Asset Turnover0.61420.46180.64870.65790.70770.4871
Inventory Turnover Ratio4.23042.99422.54972.97773.59033.2812
Receiveable Turnover5.95389.14796.95817.942717.689617.7904
Days Sales In Receivables61.305239.952.456945.953920.633620.5167
ROE - Return On Equity-153.2021-89.9186-107.0682-87.8431-43.1004-120.4027
Return On Tangible Equity-153.2021-89.9186-107.0683-87.8431-43.1004-120.4025
ROA - Return On Assets-56.8531-60.2332-63.9828-53.9403-24.1757-53.1876
ROI - Return On Investment-153.2021-79.6784-92.4312-73.8038-35.8196-95.9675
Book Value Per Share0.35870.75920.74050.91360.91940.7433
Operating Cash Flow Per Share-0.02170.14720.1231-0.12870.097-0.2551
Free Cash Flow Per Share-0.02650.23170.1167-0.18120.0804-0.2635

Porovnání s konkurencí: Akcie PACB

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
PACB 0.00 N/A 28.24 % 50.00 % -30.77 % 15.25 37.27 %
Akcie FLDM N/A 0.49 31.68 % 175.00 % -45.84 % 2.88 -38.38 %
Akcie GE N/A 0.25 -0.81 % 12.50 % -7.19 % 25.37 7.16 %
Akcie ILMN 77.93 2.12 18.35 % 10.78 % 15.76 % 12.58 20.25 %
Akcie LMNX 73.98 30.09 27.73 % -25.93 % 4.97 % 3.38 3.56 %
Akcie NSTG 0.00 N/A 14.43 % -3.57 % -45.77 % 6.46 -93.83 %
Akcie PKI 16.04 36.30 63.10 % -21.05 % 31.09 % 5.06 19.24 %
Akcie TMO 26.53 7.52 45.73 % -18.29 % 24.87 % 6.60 19.79 %

Nedávné obchody insiderů: Akcie PACB

Jméno Obchod Cena Objem
Michael Hunkapiller
Director
Prodej
20 Nov 2020
$15.06 $6,018,518
Michael Hunkapiller
Director
Prodej
24 Nov 2020
$14.39 $21,470
Michael Hunkapiller
Director
Option
21 Dec 2020
$2.95 $2,065,000
Michael Hunkapiller
Director
Prodej
20 Jan 2021
$37.53 $23,433,882
Michael Hunkapiller
Director
Option
25 Jan 2021
$6.14 $769,993
David Botstein
Director
Option
12 Feb 2021
$4.42 $707,200
Randall S Livingston
Director
Option
12 Feb 2021
$4.36 $294,300
Lucy Shapiro
Director
Prodej
12 Feb 2021
$50.40 $5,123,966
Kathy Ordonez
Director
Prodej
16 Feb 2021
$47.99 $10,594,800
Eric Schaefer
Chief Accounting Officer
Prodej
22 Feb 2021
$39.20 $150,606
Michael Hunkapiller
Director
Option
22 Feb 2021
$5.80 $3,494,198

Diskuze k akciím PACB